HWAM
Hennion & Walsh Asset Management’s BioXcel Therapeutics BTAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-39,368
| Closed | -$14.7K | – | 873 |
|
|
2024
Q4 | $14.7K | Sell |
39,368
-731
| -2% | -$273 | ﹤0.01% | 851 |
|
|
2024
Q3 | $24.5K | Sell |
40,099
-500
| -1% | -$305 | ﹤0.01% | 866 |
|
|
2024
Q2 | $52K | Buy |
40,599
+3,197
| +9% | +$4.09K | ﹤0.01% | 838 |
|
|
2024
Q1 | $105K | Buy |
37,402
+910
| +2% | +$2.57K | 0.01% | 831 |
|
|
2023
Q4 | $108K | Buy |
36,492
+2,552
| +8% | +$7.53K | 0.01% | 810 |
|
|
2023
Q3 | $85.9K | Buy |
33,940
+16,032
| +90% | +$40.6K | 0.01% | 787 |
|
|
2023
Q2 | $119K | Sell |
17,908
-19,979
| -53% | -$133K | 0.01% | 781 |
|
|
2023
Q1 | $707K | Sell |
37,887
-1,298
| -3% | -$24.2K | 0.04% | 433 |
|
|
2022
Q4 | $842K | Buy |
39,185
+4,954
| +14% | +$106K | 0.05% | 374 |
|
|
2022
Q3 | $405K | Sell |
34,231
-474
| -1% | -$5.61K | 0.03% | 531 |
|
|
2022
Q2 | $458K | Sell |
34,705
-516
| -1% | -$6.81K | 0.03% | 506 |
|
|
2022
Q1 | $736K | Buy |
35,221
+719
| +2% | +$15K | 0.04% | 419 |
|
|
2021
Q4 | $701K | Buy |
34,502
+2,158
| +7% | +$43.8K | 0.03% | 450 |
|
|
2021
Q3 | $982K | Buy |
32,344
+11,074
| +52% | +$336K | 0.05% | 356 |
|
|
2021
Q2 | $618K | Buy |
+21,270
| New | +$618K | 0.03% | 476 |
|